TD-HV643026

Balugrastim(TD-HV643026) is a research-grade recombinant antibody targetingCD114. Produced in mammalian cells with native-like glycosylation.HighlightsResearch Grade— For PK/PD studies, assay development, and ADA research.Native Glycosylation— Mammalian expression ensures native-like patterns.

Human

ELISA, Functional assay, Research in vivo

Human

Fusion - ALB (albumin, human serum albumin, HSA) 25-609 - CSF3 (colony stimulating factor 3, GCSF, granulocyte colony-stimulating factor, G-CSF)

G-CSF receptor, CSF3R, GCSFR, G-CSF-R, CD114, Granulocyte colony-stimulating factor receptor

Please contact the lab for this information.

>95% purity as determined by SDS-PAGE.

Purified by ion exchange chromatography.

Q99062

Liquid

0.01M PBS, pH 7.4.Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.

ALB-rG-CSF, G-CSF-HAS, HSA-rG-CSF, EGRANLI™, NEUGRANIN™, ALBUGRANIN™

Balugrastim (CG 10639) is a novel long-acting recombinant granulocyte colony-stimulating factor (G-CSF) obtained by means of a genetic fusion between recombinant human serum albumin and granulocyte colony-stimulating factor. Balugrastim can be used for the research of breast cancer.• Characterization of G-CSF receptor expression in medulloblastoma., PMID:32642714• Gene Expression ofCSF3R/CD114 Is Associated with Poorer Patient Survival in Glioma., PMID:38474265• CSF3R/CD114 mediates infection-dependent transition to severe asthma., PMID:30312710• Protective Role of Myeloid Cells Expressing a G-CSF Receptor Polymorphism in an Induced Model of Lupus., PMID:29868014

For research use only. Not suitable for clinical or therapeutic use.